Prof. Uriel Levy is the head of the nano-opto lab and the director of the center for nanoscience and nanotechnology at the Hebrew University, Jerusalem Israel. His research spans over diverse aspects of nanophotonics and light-matter interactions, with focus on device-oriented research. Over the years, he pioneered several key concepts in nanophotonics, including silicon-based photodetection in the short wave infrared (SWIR), nanoscale polarization optics, and the chip-scale atomic vapor technology.
His research covers both fundamentals of light-matter interactions, as well as diverse applications in imaging, communications, sensing and metrology, energy harvesting, memories, displays and other chip scale optoelectronic devices. Prof. Levy has strong ties to the industry and a proven track record in tech transfer. Prof. Levy is the co-founder of TriEye, where he is developing CMOS based cost-effective SWIR imaging solutions for the automotive industry and for other verticals. He was also a co-founder and a VP R&D of Civcom, where he developed solutions for optical telecommunications. Over the years, Prof. Levy published over 150 journal papers, presented his results in hundreds of invited talks and he holds dozens of patents. Prof. Levy is a fellow of the optical society of America and is the recipient of several notable honors, including the Kaye innovation award, an ERC consolidator grant, the President Young Investigator Award of the Hebrew University of Jerusalem, and the Rothschild Post-Doctoral Fellowship. He holds a BSc in Physics and materials science from the Technion and a PhD in electro optics from the Tel Aviv University. Prior to joining the Hebrew University, he spent nearly four years as a researcher in the University of California, San Diego.
Luba Greenwood is a Harvard Professor and investor, a leading figure in the Pharma and Digital Health world, and served in management roles at companies such as Google and Roche. Greenwood is also the Managing Partner of the Dana-Farber Cancer Institute’s venture fund.
She is a veteran pharmaceutical, diagnostics, health devices, tech investor, and company builder. Greenwood served in leadership roles at Google Life Sciences, Verily, and was a VP of Global Business Development and Mergers & Acquisitions at Roche, where she also established and led the East Coast Innovation Hub. Luba has led $5B+ in deals and investments across multiple therapeutic areas and life sciences and tech sectors globally. She has also co-founded biotech and digital health companies in the immunotherapy, women’s health, and microbiome space, including Incysus and Luca Biologics. Luba serves as a Senior Advisor to the CEO of the Dana-Farber Cancer Institute, lectures at Harvard University in the School of Engineering and Applied Sciences, and advises the Wyss Center for Bio and Neuro-engineering. She serves on numerous boards, including the Massachusetts Biotechnology Council (MassBio), Brooklyn ImmunoTherapeutics, and Entrinsic Bioscience. She is also on the investor review committee for the National Cancer Institute. As a former litigator who started her career at Wilmer Hale, Luba also brings to Grove Ventures extensive legal knowledge in the fields of regulation, policy, data privacy, and IP.
Avraham (Poza) Meir is an industry veteran who held multiple technology leadership roles at successful companies.
Mr. Meir served as the CTO of M-Systems, VP of Engineering at SanDisk, CTO and GM of Anobit’s Enterprise SSD department, CTO of Apple Israel, and the Chief Strategy Officer of Elastifile.
He holds a BSEE degree from Tel Aviv University, Summa Cum Laude.